Back
ESC Professional Premium Access

A phase 2a trial investigating ninerafaxstat - a novel cardiac mitotrope for the treatment of diabetic cardiomyopathy (IMPROVE-DiCE)

Session: CMR in the evaluation of cardiomyopathies and heart failure
Topic: Myocardial Disease
Speaker: Doctor M. Hundertmark (Bern, CH)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Moritz Jens Hundertmark

Bern University Hospital, Inselspital, Bern (Switzerland)
1 follower

7 more presentations in this session

Investigating myocardial energetic deficit across the spectrum of cardiac disease

Speaker: Doctor A. Henry (Oxford, GB)

Access
Abstract
Slides
Like
Thumbnail

Prognostic implications of trabecular complexity measured by fractal analysis in left ventricular noncompaction

Speaker: Miss A. Romero Valero (Elche, ES)

Access
Abstract
Slides
Like
Thumbnail

Unmasking systolic impairment in HFpEF by cardiovascular magnetic resonance derived hemodynamic force assessment: Insights from the HFpEF stress trial

Speaker: Doctor S. Backhaus (Bad Nauheim, DE)

Access
Abstract
Slides
Like
Thumbnail

Hepatic T1-time predicts cardiovascular risk in all-comers referred for cardiovascular magnetic resonance.

Speaker: Doctor K. Mascherbauer (Vienna, AT)

Access
Abstract
Slides
Like
Thumbnail

Ratio between left and right ventricular end-diastolic volumes and outcomes in patients with heart failure and preserved ejection fraction

Speaker: Doctor A. Aimo (Pisa, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

CMR in the evaluation of cardiomyopathies and heart failure

Speakers: Doctor M. Hundertmark, Doctor A. Henry, Miss A. Romero Valero, Doctor S. Backhaus, Doctor K. Mascherbauer...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources